Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines

Messenger RNA (mRNA)-based vaccines have shown promise against infectious diseases and several types of cancer in the last two decades. Their promise can be attributed to their safety profiles, high potency, and ability to be rapidly and affordably manufactured. Now, many RNA-based vaccines are bein...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfagih, Iman M., Aldosari, Basmah, AlQuadeib, Bushra, Almurshedi, Alanood, Alfagih, Mariyam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823281/
https://www.ncbi.nlm.nih.gov/pubmed/33396817
http://dx.doi.org/10.3390/pharmaceutics13010045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823281/
https://www.ncbi.nlm.nih.gov/pubmed/33396817
http://dx.doi.org/10.3390/pharmaceutics13010045

Ejemplares similares